Levodopa-carbidopa intestinal gel (LCIG) and levodopa-carbidopa-entacapone intestinal gel (LECIG) for Parkinson’s disease (adults)

Document first published:
Page updated:
Topic:
Publication type:

NHS England will routinely commission treatment with levodopa-carbidopa intestinal gel (LCIG) and levodopa-carbidopa-entacapone intestinal gel (LECIG) for patients with advanced Parkinson’s disease within the criteria set out in this document.

Document

Levodopa-carbidopa intestinal gel (LCIG) and levodopa-carbidopa-entacapone intestinal gel (LECIG) for Parkinson’s disease (adults)

Levodopa-carbidopa intestinal gel (LCIG) and levodopa-carbidopa-entacapone intestinal gel (LECIG) for Parkinson’s disease (adults)

  • PDF
  • 291 KB
  • 12 pages

Summary

Updated May 2025.